RTN4 and schizophrenia: It is therefore not surprising that the disruption of a Nogo signaling pathway in the developing brain has been suggested to play a role in neuropsychiatric diseases of neurodevelopmental origin, most notably schizophrenia and bipolar disorder (Willi and Schwab, 2013).